JP2003185668A - 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 - Google Patents
病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質Info
- Publication number
- JP2003185668A JP2003185668A JP2002298010A JP2002298010A JP2003185668A JP 2003185668 A JP2003185668 A JP 2003185668A JP 2002298010 A JP2002298010 A JP 2002298010A JP 2002298010 A JP2002298010 A JP 2002298010A JP 2003185668 A JP2003185668 A JP 2003185668A
- Authority
- JP
- Japan
- Prior art keywords
- analyte
- ligand
- detection
- capture
- tethered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 65
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 64
- 230000001717 pathogenic effect Effects 0.000 title abstract description 15
- 230000001988 toxicity Effects 0.000 title abstract 2
- 231100000419 toxicity Toxicity 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 175
- 239000003446 ligand Substances 0.000 claims abstract description 157
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 26
- -1 heme compound Chemical class 0.000 claims abstract description 23
- 150000004676 glycans Chemical class 0.000 claims abstract description 9
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 9
- 239000005017 polysaccharide Substances 0.000 claims abstract description 9
- 238000002835 absorbance Methods 0.000 claims abstract description 8
- 239000012491 analyte Substances 0.000 claims description 132
- 238000001514 detection method Methods 0.000 claims description 74
- 244000005700 microbiome Species 0.000 claims description 61
- 239000000758 substrate Substances 0.000 claims description 35
- 241000894006 Bacteria Species 0.000 claims description 28
- 210000004027 cell Anatomy 0.000 claims description 27
- 230000000813 microbial effect Effects 0.000 claims description 22
- 239000000589 Siderophore Substances 0.000 claims description 15
- 239000003550 marker Substances 0.000 claims description 15
- 231100000654 protein toxin Toxicity 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 125000000524 functional group Chemical group 0.000 claims description 13
- 108700012359 toxins Proteins 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 230000002285 radioactive effect Effects 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- 230000003287 optical effect Effects 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 241000700605 Viruses Species 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 229910000077 silane Inorganic materials 0.000 claims description 7
- 241000233866 Fungi Species 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 239000007822 coupling agent Substances 0.000 claims description 6
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 238000000386 microscopy Methods 0.000 claims description 4
- 125000000962 organic group Chemical group 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 125000003700 epoxy group Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 238000007885 magnetic separation Methods 0.000 claims description 2
- 229920000768 polyamine Polymers 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 229920000232 polyglycine polymer Polymers 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 2
- 239000000985 reactive dye Substances 0.000 claims 24
- 238000004020 luminiscence type Methods 0.000 claims 7
- 101710116435 Outer membrane protein Proteins 0.000 claims 4
- 230000001086 cytosolic effect Effects 0.000 claims 4
- 150000002632 lipids Chemical class 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 3
- 238000010791 quenching Methods 0.000 claims 3
- 230000000171 quenching effect Effects 0.000 claims 3
- 239000006249 magnetic particle Substances 0.000 claims 2
- 101700012268 Holin Proteins 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 238000012856 packing Methods 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 241001515965 unidentified phage Species 0.000 claims 1
- 241000894007 species Species 0.000 abstract description 4
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 238000011156 evaluation Methods 0.000 abstract description 2
- 238000002796 luminescence method Methods 0.000 abstract description 2
- 244000053095 fungal pathogen Species 0.000 abstract 2
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 238000002795 fluorescence method Methods 0.000 abstract 1
- 238000000059 patterning Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 35
- 239000000523 sample Substances 0.000 description 19
- 244000052616 bacterial pathogen Species 0.000 description 14
- 239000011521 glass Substances 0.000 description 12
- 244000000010 microbial pathogen Species 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 10
- 244000052769 pathogen Species 0.000 description 10
- 231100000331 toxic Toxicity 0.000 description 10
- 230000002588 toxic effect Effects 0.000 description 10
- 125000005647 linker group Chemical group 0.000 description 7
- 150000003278 haem Chemical class 0.000 description 6
- 229920001542 oligosaccharide Polymers 0.000 description 6
- 150000002482 oligosaccharides Chemical class 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 4
- 244000037640 animal pathogen Species 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- UBQYURCVBFRUQT-UHFFFAOYSA-N N-benzoyl-Ferrioxamine B Chemical compound CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN UBQYURCVBFRUQT-UHFFFAOYSA-N 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- 239000002095 exotoxin Substances 0.000 description 3
- 231100000776 exotoxin Toxicity 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 2
- 101001023095 Anemonia sulcata Delta-actitoxin-Avd1a Proteins 0.000 description 2
- 101000641989 Araneus ventricosus Kunitz-type U1-aranetoxin-Av1a Proteins 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 101001028691 Carybdea rastonii Toxin CrTX-A Proteins 0.000 description 2
- 101000685083 Centruroides infamatus Beta-toxin Cii1 Proteins 0.000 description 2
- 101000685085 Centruroides noxius Toxin Cn1 Proteins 0.000 description 2
- 101001028688 Chironex fleckeri Toxin CfTX-1 Proteins 0.000 description 2
- 101000644407 Cyriopagopus schmidti U6-theraphotoxin-Hs1a Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 101000679608 Phaeosphaeria nodorum (strain SN15 / ATCC MYA-4574 / FGSC 10173) Cysteine rich necrotrophic effector Tox1 Proteins 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 101710101607 Toxic shock syndrome toxin-1 Proteins 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000004630 atomic force microscopy Methods 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 238000002983 circular dichroism Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 239000000147 enterotoxin Substances 0.000 description 2
- 231100000655 enterotoxin Toxicity 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZCFFYALKHPIRKJ-UHFFFAOYSA-N 3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-21,24-diium-2-yl]propanoate Chemical compound N1C(C=C2C(=C(C)C(=CC=3C(C)=C(CCC(O)=O)C(N=3)=C3)N2)C=C)=C(C)C(C=C)=C1C=C1C(C)=C(CCC(O)=O)C3=N1 ZCFFYALKHPIRKJ-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 108020004513 Bacterial RNA Proteins 0.000 description 1
- 241000589567 Brucella abortus Species 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001647372 Chlamydia pneumoniae Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 101100346656 Drosophila melanogaster strat gene Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 101000867232 Escherichia coli Heat-stable enterotoxin II Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 231100000757 Microbial toxin Toxicity 0.000 description 1
- 229930183781 Mycobactin Natural products 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229910003849 O-Si Inorganic materials 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910003872 O—Si Inorganic materials 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000010065 bacterial adhesion Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940056450 brucella abortus Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000002101 electrospray ionisation tandem mass spectrometry Methods 0.000 description 1
- 229940096118 ella Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 108010008385 glycolipid receptor Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
- 229940025294 hemin Drugs 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000797 iron chelating agent Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- XZGYBQIQSLSHDH-COEJQBHMSA-N mycobactin Chemical compound C1CCCN(O)C(=O)C1NC(=O)C(C)C(CC)OC(=O)C(CCCCN(O)C(=O)\C=C/CCCCCCCCCCCCCCC)NC(=O)C(N=1)COC=1C1=C(C)C=CC=C1O XZGYBQIQSLSHDH-COEJQBHMSA-N 0.000 description 1
- RLQJSUCFBHXPHA-UHFFFAOYSA-N n-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-n'-(5-aminopentyl)-n'-hydroxybutanediamide;iron Chemical compound [Fe].CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN RLQJSUCFBHXPHA-UHFFFAOYSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
- LLMKLMMXMOTPRU-YOAXHERRSA-N vibriobactin Chemical compound O=C([C@@H]1N=C(O[C@H]1C)C=1C(=C(O)C=CC=1)O)NCCCN(C(=O)[C@@H]1[C@H](OC(=N1)C=1C(=C(O)C=CC=1)O)C)CCCNC(=O)C1=CC=CC(O)=C1O LLMKLMMXMOTPRU-YOAXHERRSA-N 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
- B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
- B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/999,159 | 2001-11-01 | ||
| US09/999,159 US6780602B2 (en) | 2001-11-01 | 2001-11-01 | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
Related Child Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004151017A Division JP2004317520A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151015A Division JP2004309493A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151018A Division JP2004333503A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151016A Division JP2004309494A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003185668A true JP2003185668A (ja) | 2003-07-03 |
| JP2003185668A5 JP2003185668A5 (enExample) | 2005-04-07 |
Family
ID=25545977
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002298010A Pending JP2003185668A (ja) | 2001-11-01 | 2002-10-10 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151018A Pending JP2004333503A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151017A Pending JP2004317520A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151016A Pending JP2004309494A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151015A Pending JP2004309493A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004151018A Pending JP2004333503A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151017A Pending JP2004317520A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151016A Pending JP2004309494A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
| JP2004151015A Pending JP2004309493A (ja) | 2001-11-01 | 2004-05-20 | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US6780602B2 (enExample) |
| EP (1) | EP1308520A3 (enExample) |
| JP (5) | JP2003185668A (enExample) |
| CN (1) | CN1417347A (enExample) |
| CA (1) | CA2402588A1 (enExample) |
| HK (1) | HK1054054A1 (enExample) |
| SG (5) | SG152039A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006124346A (ja) * | 2004-10-29 | 2006-05-18 | Nagoya Institute Of Technology | 細胞固定化材 |
| JP2021522525A (ja) * | 2018-04-19 | 2021-08-30 | ファースト ライト バイオサイエンシーズ， インコーポレイテッド | 標的の検出 |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10138072A1 (de) * | 2001-08-03 | 2003-02-27 | Fraunhofer Ges Forschung | Verfahren und Vorrichtung zum Bestimmen von Proteinen auf einem Reaktionsträger |
| US6780602B2 (en) * | 2001-11-01 | 2004-08-24 | Microbiosystems, Limited Partnership | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
| CN100362021C (zh) * | 2003-06-06 | 2008-01-16 | 河南大学 | 山药多糖-铁复合物及其制备工艺 |
| CN1914332A (zh) * | 2003-12-15 | 2007-02-14 | 快速实验室微系统公司 | 用于鉴定微生物的电化学分析 |
| US20070141597A1 (en) * | 2005-10-25 | 2007-06-21 | Harmon H J | Biomimetic Biodetector of Toxins, Viruses, Bacteria, and Biological Factors |
| JP2008249534A (ja) * | 2007-03-30 | 2008-10-16 | Sanyo Chem Ind Ltd | 免疫測定用担体 |
| WO2009036105A2 (en) * | 2007-09-11 | 2009-03-19 | Baxter International Inc | Infusion therapy sensor system |
| AU2009296528A1 (en) * | 2008-09-24 | 2010-04-01 | Straus Holdings Inc. | Imaging analyzer for testing analytes |
| US8647835B2 (en) | 2008-10-31 | 2014-02-11 | BIO MéRIEUX, INC. | Methods for separation, characterization and/or identification of microorganisms using spectroscopy |
| WO2010062356A1 (en) * | 2008-10-31 | 2010-06-03 | Biomerieux, Inc. | Methods for separation, characterization and/or identification of microorganisms using spectroscopy |
| EP2364356B1 (en) * | 2008-10-31 | 2019-06-19 | Biomerieux, Inc | Methods for detection and identification of microorganisms |
| ES2538497T3 (es) * | 2008-10-31 | 2015-06-22 | Biomerieux, Inc | Métodos para la identificación de microorganismos usando espectrometría de masas |
| US10059975B2 (en) * | 2008-10-31 | 2018-08-28 | Biomerieux, Inc. | Methods for the isolation and identification of microorganisms |
| WO2010062351A1 (en) * | 2008-10-31 | 2010-06-03 | Biomerieux, Inc. | Methods for separation, characterization, and/or identification of microorganisms using raman spectroscopy |
| KR20110091719A (ko) * | 2008-10-31 | 2011-08-12 | 바이오메리욱스, 인코포레이티드. | 식별제를 사용한 미생물의 분리 및 특성규명 방법 |
| CN104502317B (zh) * | 2008-12-16 | 2017-10-17 | 生物梅里埃有限公司 | 用于在固体或半固体介质上表征微生物的方法 |
| US8666673B2 (en) | 2010-05-14 | 2014-03-04 | Biomerieux, Inc | Identification and/or characterization of a microbial agent using taxonomic hierarchical classification |
| WO2011149447A1 (en) | 2010-05-14 | 2011-12-01 | Biomerieux, Inc. | Identification and/or characterization of a microbial agent using taxonomic hierarchical classification |
| CA2803348A1 (en) | 2010-06-25 | 2012-04-19 | Purdue Research Foundation | Pathogen detection |
| CN104697989B (zh) * | 2013-12-06 | 2017-08-25 | 中国科学院理化技术研究所 | 含Fe3+的复合黏土的制备及其变色法检测水体生物毒性的方法 |
| US9880159B2 (en) | 2014-10-01 | 2018-01-30 | Linda S. Powers | Cartridge-based detection system |
| AU2016245213A1 (en) * | 2015-04-09 | 2017-11-23 | Koninklijke Philips N.V. | Method and apparatus for estimating the quantity of microorganisms within a taxonomic unit in a sample |
| US9867250B1 (en) | 2015-04-20 | 2018-01-09 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | System having a configurable pico-second pulsed LED driver circuit and photomultiplier tube biasing and gating circuits for real-time, time-resolved transient recording of fluorescence |
| WO2018106931A1 (en) * | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
| EP4056263B1 (en) | 2016-12-16 | 2024-08-28 | The Brigham and Women's Hospital, Inc. | System and method for protein corona sensor array for early detection of diseases |
| US20210072255A1 (en) | 2016-12-16 | 2021-03-11 | The Brigham And Women's Hospital, Inc. | System and method for protein corona sensor array for early detection of diseases |
| WO2020096631A2 (en) | 2018-11-07 | 2020-05-14 | Seer, Inc. | Compositions, methods and systems for protein corona analysis and uses thereof |
| AU2020247907B2 (en) | 2019-03-26 | 2025-12-11 | Seer, Inc. | Compositions, methods and systems for protein corona analysis from biofluids and uses thereof |
| JP7441303B2 (ja) | 2019-08-05 | 2024-02-29 | シアー， インコーポレイテッド | サンプル調製、データ生成、タンパク質コロナ分析のためのシステムおよび方法 |
| CN116529393A (zh) | 2020-08-25 | 2023-08-01 | 禧尔公司 | 用于测定蛋白质和核酸的组合物和方法 |
| CN114359897A (zh) * | 2020-10-13 | 2022-04-15 | 深圳赛威玛智能科技有限公司 | 病原微生物的智能识别方法、计算机设备及可读存储介质 |
| CN117225491B (zh) * | 2023-11-15 | 2024-01-16 | 拜奥智能科技(山东)有限公司 | 一种可减少氨残留的定氮仪防溅瓶 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5958790A (en) | 1984-12-20 | 1999-09-28 | Nycomed Imaging As | Solid phase transverse diffusion assay |
| US5089395A (en) | 1985-02-27 | 1992-02-18 | University Of Cincinnati | Viable microorganism detection by induced fluorescence |
| US4746604A (en) | 1985-05-24 | 1988-05-24 | Enzo Biochem, Inc. | Specific binding assays utilizing a viable cell as a label |
| US5415997A (en) | 1987-07-28 | 1995-05-16 | Biotechnology Australia Pty Limited | Method for detecting low levels of microorganisms |
| US4953561A (en) * | 1989-09-18 | 1990-09-04 | Cancer Diagnostics, Inc. | Urine testing module and method of collecting urine antigen |
| US5766933A (en) * | 1989-04-26 | 1998-06-16 | Diagnostic Products Corporation | Method and element for measuring analytes in biological fluids using immobilized binder--analyte labeled complex |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6017722A (en) | 1991-04-04 | 2000-01-25 | Board Of Regents, The University Of Texas System | Luminous bacteria and methods for the isolation, identification and quantitation of toxicants |
| CA2107899A1 (en) * | 1991-04-10 | 1992-10-11 | Gunars Edwin Valkirs | Novel conjugates and assays for simultaneous detection of multiple ligands |
| DK39592D0 (da) | 1992-03-25 | 1992-03-25 | Safefood Micro Systsm As | Method of detecting microorganisms |
| GB9212416D0 (en) | 1992-06-11 | 1992-07-22 | Medical Res Council | Reversible binding substances |
| WO1994003812A1 (en) | 1992-07-31 | 1994-02-17 | Syntex (U.S.A.) Inc. | Photoactivatable chemiluminescent matrices |
| US6001556A (en) | 1992-11-13 | 1999-12-14 | The Regents Of The University Of California | Polymeric assay film for direct colorimetric detection |
| US5576220A (en) * | 1993-02-19 | 1996-11-19 | Arris Pharmaceutical Corporation | Thin film HPMP matrix systems and methods for constructing and displaying ligands |
| US5415999A (en) | 1993-07-09 | 1995-05-16 | Biocircuits Corporation | Fluorescent lipid polymer-macromolecular ligand compositions as detection element in ligand assays |
| US5986076A (en) | 1994-05-11 | 1999-11-16 | Trustees Of Boston University | Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| AU2636995A (en) | 1994-05-18 | 1995-12-05 | Research And Development Institute, Inc. | Simple, rapid method for the detection, identification and enumeration of specific viable microorganisms |
| AUPN214095A0 (en) | 1995-04-03 | 1995-04-27 | Australian Water Technologies Pty Ltd | Method for detecting microorganisms using flow cytometry |
| US5731148A (en) | 1995-06-07 | 1998-03-24 | Gen-Probe Incorporated | Adduct protection assay |
| US6159689A (en) | 1995-11-10 | 2000-12-12 | Genera Technologies Limited | Methods of capture and assay procedures |
| US5741662A (en) | 1995-12-18 | 1998-04-21 | Quidel Corporation | Direct stain specific binding assays for microorganisms |
| GB9608540D0 (en) | 1996-04-25 | 1996-07-03 | Medical Res Council | Isolation of enzymes |
| AU3135097A (en) | 1996-05-22 | 1997-12-09 | Johns Hopkins University, The | Methods of detection utilizing modified bacteriophage |
| US5760406A (en) * | 1996-06-03 | 1998-06-02 | Powers; Linda | Method and apparatus for sensing the presence of microbes |
| US5965532A (en) * | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
| US5972715A (en) | 1996-12-23 | 1999-10-26 | Bayer Corporation | Use of thermochromic liquid crystals in reflectometry based diagnostic methods |
| US5888066A (en) * | 1997-01-28 | 1999-03-30 | Diro, Inc. | Converter assembly for threaded dental implants |
| FR2758884B1 (fr) * | 1997-01-30 | 1999-04-02 | Bio Merieux | Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu |
| US6087088A (en) | 1997-01-31 | 2000-07-11 | Bayer Corporation | Binding assays using more than one label for determining analyte in the presence of interfering factors |
| US5763158A (en) | 1997-02-06 | 1998-06-09 | The United States Of America As Represented By The Secretary Of The Army | Detection of multiple antigens or antibodies |
| US5888760A (en) | 1997-04-10 | 1999-03-30 | Dade Microscan Inc. | Universal test systems and methods of use thereof for identifying multiple families of microorganisms |
| CZ297165B6 (cs) * | 1997-04-21 | 2006-09-13 | Randox Laboratories Ltd. A British Company Of Ardmore | Zpusob výroby zarízení s pevnou fází k provádení multianalytních rozboru |
| WO1998049557A1 (en) * | 1997-04-28 | 1998-11-05 | B-E Safe, Inc. | Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states |
| US6197568B1 (en) | 1997-07-29 | 2001-03-06 | The Regents Of The University Of Michigan | Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms |
| BR9813307A (pt) | 1997-10-27 | 2000-08-22 | Idexx Lab Inc | Dispositivo e métodos para determinação de analisado em uma solução |
| US5912115A (en) | 1997-12-12 | 1999-06-15 | Akzo Nobel, N.V. | Evacuated sensor device for detecting microorganisms in blood samples, and method thereof |
| US5976827A (en) | 1997-12-12 | 1999-11-02 | Akzo Nobel, N.V. | Sensor device for detecting microorganisms and method therefor |
| US6214628B1 (en) | 1998-01-14 | 2001-04-10 | Joseph R. Lakowicz | Method of conducting an assay of a sample containing an analyte of interest |
| US5968766A (en) * | 1998-03-31 | 1999-10-19 | B.E. Safe | Method and apparatus for sensing the presence of microbes |
| EP1079845A4 (en) * | 1998-06-08 | 2001-03-07 | Advanced Medicine Inc | NEW THERAPEUTIC SUBSTANCES FOR MACROMOLECULAR STRUCTURES |
| US6051388A (en) | 1998-12-22 | 2000-04-18 | Toxin Alert, Inc. | Method and apparatus for selective biological material detection |
| EP1177441A1 (en) * | 1999-05-10 | 2002-02-06 | Prolinx, Inc. | Cell separation device and methods for use |
| US6699677B1 (en) * | 1999-12-20 | 2004-03-02 | Chemocentryx, Inc. | Tethered ligands and methods of use |
| US6395504B1 (en) * | 2000-09-01 | 2002-05-28 | New Horizons Diagnostics Corp. | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants |
| US20020187464A1 (en) * | 2000-09-22 | 2002-12-12 | Klempner Mark S. | Microarray-based method for rapid identification of cells, microorganisms, or protein mixtures |
| DE60141171D1 (de) * | 2000-11-27 | 2010-03-11 | Intelligent Medical Devices Ll | Klinische intelligente diagnostische vorrichtungen und verfahren |
| US6780602B2 (en) * | 2001-11-01 | 2004-08-24 | Microbiosystems, Limited Partnership | Taxonomic identification of pathogenic microorganisms and their toxic proteins |
| US20060257929A1 (en) * | 2003-11-12 | 2006-11-16 | Microbiosystems, Limited Partnership | Method for the rapid taxonomic identification of pathogenic microorganisms and their toxic proteins |
-
2001
- 2001-11-01 US US09/999,159 patent/US6780602B2/en not_active Expired - Fee Related
-
2002
- 2002-09-10 CA CA002402588A patent/CA2402588A1/en not_active Abandoned
- 2002-09-27 SG SG200407090-0A patent/SG152039A1/en unknown
- 2002-09-27 SG SG200407091-8A patent/SG143054A1/en unknown
- 2002-09-27 SG SG200407092-6A patent/SG145552A1/en unknown
- 2002-09-27 SG SG200406358-2A patent/SG152902A1/en unknown
- 2002-09-27 SG SG200205915-2A patent/SG130937A1/en unknown
- 2002-09-27 EP EP02021593A patent/EP1308520A3/en not_active Ceased
- 2002-09-27 CN CN02143520A patent/CN1417347A/zh active Pending
- 2002-10-10 JP JP2002298010A patent/JP2003185668A/ja active Pending
-
2003
- 2003-09-09 HK HK03106390.0A patent/HK1054054A1/zh unknown
- 2003-11-12 US US10/706,543 patent/US20050032115A1/en not_active Abandoned
- 2003-11-12 US US10/706,542 patent/US20050026140A1/en not_active Abandoned
- 2003-11-12 US US10/706,547 patent/US20040096910A1/en not_active Abandoned
- 2003-11-12 US US10/706,544 patent/US20050026141A1/en not_active Abandoned
-
2004
- 2004-05-20 JP JP2004151018A patent/JP2004333503A/ja active Pending
- 2004-05-20 JP JP2004151017A patent/JP2004317520A/ja active Pending
- 2004-05-20 JP JP2004151016A patent/JP2004309494A/ja active Pending
- 2004-05-20 JP JP2004151015A patent/JP2004309493A/ja active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006124346A (ja) * | 2004-10-29 | 2006-05-18 | Nagoya Institute Of Technology | 細胞固定化材 |
| JP2021522525A (ja) * | 2018-04-19 | 2021-08-30 | ファースト ライト バイオサイエンシーズ， インコーポレイテッド | 標的の検出 |
| JP2023085456A (ja) * | 2018-04-19 | 2023-06-20 | ファースト ライト ダイアグノスティクス， インコーポレイテッド | 標的の検出 |
| JP7347849B2 (ja) | 2018-04-19 | 2023-09-20 | ファースト ライト ダイアグノスティクス， インコーポレイテッド | 標的の検出 |
| JP7742376B2 (ja) | 2018-04-19 | 2025-09-19 | ファースト ライト ダイアグノスティクス， インコーポレイテッド | 標的の検出 |
Also Published As
| Publication number | Publication date |
|---|---|
| SG143054A1 (en) | 2008-06-27 |
| CA2402588A1 (en) | 2003-05-01 |
| JP2004309494A (ja) | 2004-11-04 |
| US20050032115A1 (en) | 2005-02-10 |
| US20050026140A1 (en) | 2005-02-03 |
| HK1054054A1 (zh) | 2003-11-14 |
| US20030124532A1 (en) | 2003-07-03 |
| SG152902A1 (en) | 2009-06-29 |
| EP1308520A3 (en) | 2003-11-12 |
| SG152039A1 (en) | 2009-05-29 |
| JP2004317520A (ja) | 2004-11-11 |
| SG130937A1 (en) | 2007-04-26 |
| SG145552A1 (en) | 2008-09-29 |
| JP2004309493A (ja) | 2004-11-04 |
| US20040096910A1 (en) | 2004-05-20 |
| JP2004333503A (ja) | 2004-11-25 |
| EP1308520A2 (en) | 2003-05-07 |
| US20050026141A1 (en) | 2005-02-03 |
| CN1417347A (zh) | 2003-05-14 |
| US6780602B2 (en) | 2004-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003185668A (ja) | 病原性微生物の分類学的同定及び病原性微生物の毒性タンパク質 | |
| Gooding | Biosensor technology for detecting biological warfare agents: Recent progress and future trends | |
| Shan et al. | Novel strategies to enhance lateral flow immunoassay sensitivity for detecting foodborne pathogens | |
| JP7048564B2 (ja) | 微生物の検出のための方法およびシステム | |
| Lim | Detection of microorganisms and toxins with evanescent wave fiber-optic biosensors | |
| Chen et al. | Label-free screening of foodborne Salmonella using surface plasmon resonance imaging | |
| CN101971032B (zh) | 在液体培养基中通过凝集实时检测微生物的方法 | |
| WO1998049557A1 (en) | Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states | |
| Babaie et al. | Recent progress and challenges on the bioassay of pathogenic bacteria | |
| Daramola et al. | Functionalized inorganic nanoparticles for the detection of food and waterborne bacterial pathogens | |
| KR20120088202A (ko) | 미생물 검출용 바이오센서 | |
| CN105891473B (zh) | 基于金标银染信号放大技术的食源性致病菌免疫传感器的制备方法及其应用 | |
| Suaifan et al. | Magnetic beads-based nanozyme for portable colorimetric biosensing of Helicobacter pylori | |
| US20060257929A1 (en) | Method for the rapid taxonomic identification of pathogenic microorganisms and their toxic proteins | |
| AU2017321642A1 (en) | Antibody measurement method using antigen-carrying insoluble carrier particles on which antigen is immobilized by different methods, and reagent for antibody measurement | |
| JP4102360B2 (ja) | ホログラフィックセンサーを用いた微生物の検出 | |
| US10233484B2 (en) | Methods and systems for rapid detection of microorganisms using free antibodies | |
| Krizkova et al. | Microchip Capillary Electrophoresis: Quantum Dots and Paramagnetic Particles for Bacteria Immunoseparation: Rapid Superparamagnetic-Beads-Based Automated Immunoseparation of Zn-Proteins from Staphylococcus aureus with Nanogram Yield | |
| JP2002181823A (ja) | 微生物の検出方法 | |
| Liu et al. | A dual-target fluorescent assay for rapid detection of foodborne pathogens based on aptamer–magnetic bead technology | |
| JP2002181824A (ja) | 糖抗原認識性エンドトキシン測定法 | |
| Starodub et al. | Biosensors in Express Control of Quality Assurance of Products | |
| Koh et al. | A Portable Immunoassay Platform for Multiplexed Detection of Biotoxins in Clinical and Environmental Samples | |
| JP2005255714A (ja) | 生物学的認識分子結合ポリマー、製造方法および用途 | |
| Che | An immuno-electrochemical biosensor system for rapid detection of pathogenic bacteria in poultry samples |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040520 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040520 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060404 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060629 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060704 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061004 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20061114 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070213 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070417 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20081229 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090108 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090225 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090302 |